Peer Review reports
From: OnabotulinumtoxinA in chronic migraine: is the response dose dependent?
| Original Submission | ||
|---|---|---|
| 14 Dec 2021 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 20 Jan 2022 | Reviewed | Reviewer Report |
| 11 Feb 2022 | Reviewed | Reviewer Report |
| 28 Mar 2022 | Author responded | Author comments - Fred Michael Cutrer |
| Resubmission - Version 4 | ||
| 28 Mar 2022 | Submitted | Manuscript version 4 |
| 31 Mar 2022 | Reviewed | Reviewer Report |
| 31 Mar 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 1 Apr 2022 | Editorially accepted | |
| 13 Jun 2022 | Article published | 10.1186/s12883-022-02742-x |
You can find further information about peer review here.